These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Introduction: missing the target with lipid-lowering therapy. Hunninghake DB; McKenney JM Am J Manag Care; 2000 Nov; 6(19 Suppl):S992-6. PubMed ID: 11187370 [No Abstract] [Full Text] [Related]
4. Improving cholesterol control in managed care populations. McKenney JM Am J Manag Care; 2000 Nov; 6(19 Suppl):S997-1007. PubMed ID: 11187371 [TBL] [Abstract][Full Text] [Related]
5. The economics of lipid management. Mullins CD Manag Care; 2001 Nov; 10(11 Suppl):17-8; discussion 19-24. PubMed ID: 11761626 [No Abstract] [Full Text] [Related]
6. Assessing the value and affordability of cholesterol reduction in the managed care setting. Gonzalez ER; Kannewurf BS Am J Manag Care; 1998 Apr; 4(4 Suppl):S226-33; quiz S234-5. PubMed ID: 10180344 [No Abstract] [Full Text] [Related]
8. Lipid management with statins. The lower the better? Laufs U; Liao JK; Böhm M Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235 [TBL] [Abstract][Full Text] [Related]
9. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice. Davidson MH; Gandhi SK; Ohsfeldt RL; Fox KM Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088 [TBL] [Abstract][Full Text] [Related]
10. Achieving cholesterol target in a managed care organization (ACTION) trial. Straka RJ; Taheri R; Cooper SL; Smith JC Pharmacotherapy; 2005 Mar; 25(3):360-71. PubMed ID: 15843283 [TBL] [Abstract][Full Text] [Related]
14. [Regarding LDL cholesterol: the lower, the better (interview by Dr. Dirk Einecke)]. Nissen S MMW Fortschr Med; 2004 Mar; 146(13):65. PubMed ID: 15219143 [No Abstract] [Full Text] [Related]
15. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Daskalopoulou SS; Mikhailidis DP Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035 [TBL] [Abstract][Full Text] [Related]
16. [New trends in lipidology. Which patient benefits from cholesterol lowering therapy?]. Internist (Berl); 1998 Apr; 39(4 Suppl Welcher Pa):1-4. PubMed ID: 9589329 [No Abstract] [Full Text] [Related]
17. Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia. Samaha FF; McKenney J; Bloedon LT; Sasiela WJ; Rader DJ Nat Clin Pract Cardiovasc Med; 2008 Aug; 5(8):497-505. PubMed ID: 18506154 [TBL] [Abstract][Full Text] [Related]
18. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol. Corsini A; Windler E; Farnier M Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992 [TBL] [Abstract][Full Text] [Related]
19. Meet the cholesterol busters. Healy B US News World Rep; 2004 Mar 22-29; 136(10):54. PubMed ID: 15069903 [No Abstract] [Full Text] [Related]